Skip to content

Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)

Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03469505
Acronym
COPES ExTRA
Enrollment
764
Registered
2018-03-19
Start date
2019-12-27
Completion date
2025-02-20
Last updated
2025-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Chronic

Brief summary

To conduct a superiority trial of COPES versus standard Veterans Health Administration (VHA) Cognitive Behavioral Therapy Chronic Pain (CBT-CP)

Detailed description

Our prior efficacy trial found that COPES was not inferior to in-person CBT-CP and that participants attended, on average, a little over two more treatment weeks in COPES than in-person treatment, presumably due to the ease of in-home treatment attendance relative to in-person treatment.

Interventions

BEHAVIORALCOPES

Cooperative Pain Education and Self-Management for chronic pain therapy.

BEHAVIORALCBT-CP

Cognitive Behavioral Therapy for Chronic Pain

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with chronic musculoskeletal pain receiving care in VHA. * A pain-related musculoskeletal diagnosis indicated by an EHR identified ICD-9 or -10 code. * The presence of chronic pain of at least moderate severity with EHR NRS pain scores ≥ 4 in three separate months for a period of 12 months. * Absence of mental illness serious enough to have resulted in an inpatient psychiatric hospitalization in the prior 3 months excluding detoxification of alcohol or drugs. * Absence of malignant cancer diagnosis or receipt of hospice or end-of-life palliative care. * Ability to participate safely in the walking portion of the intervention as evidenced by patient-reported ability to walk at least one block and absence of diabetic foot ulcers at the time of the enrollment. * Absence of significant cognitive impairment as identified by a dementia-related diagnosis. * Availability of a touch-tone land-line or cellular telephone and no vision or hearing deficits that would impair participation verified by patient report at the time of the enrollment call.

Exclusion criteria

* Patients not fitting criteria for inclusion.

Design outcomes

Primary

MeasureTime frameDescription
Brief Pain Inventory, Interference Subscale Score4 monthsThe Brief Pain Inventory Interference Score is patient-reported pain-related interference. Data will be collected through automated IVR calls.

Secondary

MeasureTime frameDescription
Numeric Rating Score, Pain Intensity4 monthThe single average pain intensity rating question from the self-reported, Brief Pain Inventory. Data will be collected through automated IVR calls.
PEG-34 monthA Three-Item Scale Assessing Pain Intensity and Interference. Data will be collected through automated IVR calls.
Depression symptom severity4 monthsDepression symptom severity will be assessed using the 8-item Patient Health Questionnaire (PHQ-8) a widely-used measure with excellent internal consistency and stability. Data will be collected through an automated IVR.
Pain Catastrophizing Scale- Short Form4 monthsThe Pain Catastrophizing Scale (PCS)-Short Form is a validated, 3-item self-report scale that examines thoughts and feelings people may experience when they are in pain. Data will be collected through an automated IVR
The Brief Pain Inventory, Interference Score6 months, 12 monthsThe Brief Pain Inventory Interference Score is patient-reported pain-related interference. Data will be collected through automated IVR calls.
Pain Self-Efficacy4 monthsSelf-Efficacy will be assessed using 1-Item of the Pain Self-Efficacy Questionnaire. Data will be collected through automated IVR calls.
Patient Global Perception of Change4 monthsThe Patient Global Perception of Change scale is a single item measure that quantifies a participant's overall perception of improvement since beginning treatment and the clinical importance of that improvement. Participants indicate improvement on a 7 point much worse to much better scale. Data will be collected through automated IVR calls.
Pain Satisfaction Questionnaire4 monthPain satisfaction will be measured using an adapted Pain Satisfaction Questionnaire. This 5-item measure about patient self report of experience of treatment . Data will be collected through automated IVR calls.
Treatment doseUp to 12 months post baselineNumber of cognitive behavioral therapy for chronic pain sessions attended for this treatment.
Sleep Quality4 monthsSleep quality will be measured using the Insomnia Severity Index and will assess subjective sleep quality. Data will be collected through automated IVR calls.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026